Comparison of PTeye™ and FLUOBEAM® LX for Parathyroid Adenoma Detection

Overview

This preliminary case-control study compared PTeye™ and FLUOBEAM® LX devices for intraoperative identification of parathyroid adenomas (PAs). PTeye™ demonstrated a 100% identification rate with faster detection times compared to FLUOBEAM® LX, which failed to identify 15% of adenomas and required longer identification times.

Background

Parathyroid adenoma is the leading cause of primary hyperparathyroidism and surgical removal is the standard treatment. Accurate intraoperative identification of parathyroid glands is critical but challenging. Near-infrared autofluorescence (NIRAF) technology offers a label-free method to identify parathyroid tissue in real time, with two main device types: camera-based systems like FLUOBEAM® LX and probe-based systems like PTeye™. This study evaluates the performance of these two devices in detecting PAs during surgery.

Data Highlights

Key Findings

• PTeye™ identified all parathyroid adenomas (100% sensitivity) while FLUOBEAM® LX missed 15% of adenomas.
• PTeye™ enabled faster identification, with 65% of adenomas detected in under 1 minute versus none for FLUOBEAM® LX.
• FLUOBEAM® LX required longer identification times, with 20% of adenomas taking more than 5 minutes to detect.
• No significant correlation was found between identification success or time and clinicopathological variables.
• Probe-based systems like PTeye™ may offer advantages over camera-based systems in speed and reliability of PA detection.
• NIRAF technology can serve as a useful adjunct for surgeons, especially in complex or recurrent cases.

Clinical Implications

The use of PTeye™ may improve intraoperative efficiency by providing rapid and reliable identification of parathyroid adenomas, potentially reducing operative time compared to camera-based systems. Incorporating NIRAF technology can aid surgeons, particularly those less specialized in endocrine surgery, and may reduce reliance on intraoperative PTH assays or frozen section biopsies. These devices could enhance surgical outcomes in both primary and reoperative parathyroid surgeries.

Conclusion

This study supports the utility of NIRAF technology for intraoperative parathyroid adenoma detection, with probe-based PTeye™ demonstrating superior identification rates and faster detection times compared to the camera-based FLUOBEAM® LX. Adoption of such devices may optimize parathyroidectomy procedures.

References

1. Thomas et al. 2023 -- Evaluation of PTeye™ Sensitivity and Specificity in Parathyroid Identification
2. Clinicaltrials.gov NCT06788223 -- Study Registration for PTeye™ vs FLUOBEAM® LX